Zolftor is a pharmaceutical and medical product developed by Pfizer that was originally designed to treat erectile and ejaculatory dysfunction.
In a recent study published in The Journal of Sexual Medicine, researchers from the University of South Florida analyzed data from the Zolfos website and found that the pills were causing a loss of sensitivity and a loss in fluidity in the gastrointestinal tract, which may cause a lack of erection and/or ejaculation.
The study found that while Zolfts users reported a decrease in libido and ejaculation, it was not the primary cause.
However, the researchers found that those who reported a loss were more likely to have low libido.
Zolfwor, like many medications, can also affect other bodily functions, including heart rate, blood pressure, and body temperature.
When it comes to erectile function, there is no such thing as a magic pill, according to the study authors.
The Zolflor researchers suggest that the drugs should only be used by people who are at risk for erectile problems, and those who have a history of the condition, like those who suffer from erectile disorders, diabetes, and high blood pressure.
ZOLFOS does not specifically mention erectile dysfunctions in the FDA’s website, and Zolfs website does not include a warning for the effects of erectile disorder.
However in a statement to BuzzFeed News, Zolafors manufacturer, Pfizer, did acknowledge that “there are some indications for using Zoloflex to treat some patients with erectile difficulties.”
“However, the evidence supporting these specific indications are not sufficient to support the use of Zoloador as a primary treatment option for patients with mild to moderate erectile impairment,” the statement read.
The researchers also wrote that there is “no convincing evidence” to support ZolFos use as a treatment for erectic dysfunction.
However the drug can be used to treat conditions like irritable bowel syndrome, celiac disease, and Crohn’s disease.
It is also used to control bleeding in certain conditions, including asthma and asthma exacerbations.